Vascular consequences of inflammation: A position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society

Luca Zanoli*, Marie Briet, Jean P. Empana, Pedro G. Cunha, Kaisa M. Maki-Petaja, Athanase D. Protogerou, Alain Tedgui, Rhian M. Touyz, Ernesto L. Schiffrin, Bart Spronck, Philippe Bouchard, Charalambos Vlachopoulos, Rosa M. Bruno, Pierre Boutouyrie, Association for Research into Arterial Structure, Physiology (ARTERY) Society, European Society of Hypertension

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

80 Downloads (Pure)

Abstract

Inflammation is a physiological response to aggression of pathogenic agents aimed at eliminating the aggressor agent and promoting healing. Excessive inflammation, however, may contribute to tissue damage and an alteration of arterial structure and function. Increased arterial stiffness is a well recognized cardiovascular risk factor independent of blood pressure levels and an intermediate endpoint for cardiovascular events. In the present review, we discuss immune-mediated mechanisms by which inflammation can influence arterial physiology and lead to vascular dysfunction such as atherosclerosis and arterial stiffening. We also show that acute inflammation predisposes the vasculature to arterial dysfunction and stiffening, and alteration of endothelial function and that chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis are accompanied by profound arterial dysfunction which is proportional to the severity of inflammation. Current findings suggest that treatment of inflammation by targeted drugs leads to regression of arterial dysfunction. There is hope that these treatments will improve outcomes for patients.

Original languageEnglish
Pages (from-to)1682-1698
Number of pages17
JournalJournal of Hypertension
Volume38
Issue number9
DOIs
Publication statusPublished - Sept 2020

Keywords

  • ACUTE MYOCARDIAL-INFARCTION
  • C-REACTIVE PROTEIN
  • CORONARY-HEART-DISEASE
  • FLOW-MEDIATED DILATATION
  • II-INDUCED HYPERTENSION
  • INDUCED ENDOTHELIAL DYSFUNCTION
  • NECROSIS-FACTOR-ALPHA
  • PULSE-WAVE VELOCITY
  • SYSTEMIC-LUPUS-ERYTHEMATOSUS
  • T-CELLS
  • arterial stiffness
  • cardiovascular disease
  • inflammation
  • large arteries
  • pulse wave velocity

Cite this